logo
menu
← Return to the newsfeed...

Symbios receives US patent for high-density plasma reactor for water purification

The US Patent and Trademark Office (USPTO) has awarded Symbios Technologies, a developer of dynamic aqueous plasma technology platforms, a patent for its tubular high-density plasma reactor, U.S. Patent #9,346,691.

The Symbios Tubular Plasma Reactor (TPR4000) provides improved, lower-cost oxidation methods for ultrapure, process, and wastewater applications by simultaneously eliminating organic and microbial contamination without the need for added chemicals or producing a waste stream.

The design of the TPR4000 combines a continuous mixing mechanism with an air-enhanced plasma discharge system.

“This is an important milestone for our company and we are proud of the acknowledgement and protection of our intellectual property provided by this patent award from the USPTO,” said Justin Bzdek, president and CEO at Symbios.

The TPR’s design as an advanced plasma oxidation system for fluid treatment also enables it to be tuned for application in food and beverage, healthcare, power plant, fracking, wastewater treatment, and other industrial and municipal markets.

 The TPR4000 is the only technology that combines the action and chemistry of UV, ozone, peroxide, and chlorine-based technologies all in one system, providing high efficacy and lower costs when compared with alternative advanced oxidation processes.

“This cornerstone patent award is part of an ever expanding portfolio of innovation and patent submissions that highlights our capabilities to address the needs of our industrial partners, with technology made possible by research funded by the National Science Foundation (NSF) Small Business Innovation Research (SBIR) programme,” concluded Bzdek. 





147 queries in 0.337 seconds.